Clearline Capital LP Pacira Bio Sciences, Inc. Transaction History

Clearline Capital LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$27.7 - $35.48 $5.38 Million - $6.89 Million	-194,119 Reduced 58.69%	136,658 $3.99 Million
Q4 2023 Feb 14, 2024	BUY	$26.32 - $34.31 $828,685 - $1.08 Million	31,485 Added 10.52%	330,777 $11.2 Million
Q3 2023 Nov 14, 2023	BUY	$30.68 - $40.09 $9.18 Million - $12 Million	299,292 New	299,292 $9.18 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Clearline Capital LP, based on Form 13F filings with the SEC.

Stay updated on Clearline Capital LP with notifications on news.